D

Dignitana AB
STO:DIGN

Watchlist Manager
Dignitana AB
STO:DIGN
Watchlist
Price: 2.14 SEK Market Closed
Market Cap: kr172.4m

Dignitana AB
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Dignitana AB
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
D
Dignitana AB
STO:DIGN
Inventory
kr6.9m
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
11%
Elekta AB (publ)
STO:EKTA B
Inventory
kr3B
CAGR 3-Years
-3%
CAGR 5-Years
5%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Inventory
kr111.8m
CAGR 3-Years
-8%
CAGR 5-Years
6%
CAGR 10-Years
16%
Getinge AB
STO:GETI B
Inventory
kr6B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Inventory
kr1.2B
CAGR 3-Years
-11%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Inventory
kr182.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dignitana AB
Glance View

Market Cap
172.4m SEK
Industry
Health Care

Dignitana AB engages in the development, manufacture and marketing of medical technology systems related to medical cooling. The company is headquartered in Lund, Skane. The company went IPO on 2009-06-18. The company develops, manufactures and markets a medical device primarily used for scalp cooling in order to eliminate or reduce chemotherapy induced hair loss. The firm focuses on the product DigniCap, which counteracts hair loss during chemotherapy. The product is a cold cap, which when put on the patient’s head, lowers the temperature of the scalp. The low temperature reduces perfusion, delivery of blood and metabolism. The reduced blood flow results in a smaller amount of chemotherapy available for uptake in the cells, while the decreased temperature results in less absorption and reduced effects of chemotherapy. These factors together reduce the risk of hair loss. The DigniCap scalp cooling system is patented in Europe, Japan and the United States. The company has a subsidiary BrainCool AB, which focuses on producing different models of brain cooling for stroke and cardiac arrest patients.

DIGN Intrinsic Value
4.71 SEK
Undervaluation 55%
Intrinsic Value
Price
D

See Also

What is Dignitana AB's Inventory?
Inventory
6.9m SEK

Based on the financial report for Mar 31, 2025, Dignitana AB's Inventory amounts to 6.9m SEK.

What is Dignitana AB's Inventory growth rate?
Inventory CAGR 10Y
11%

Over the last year, the Inventory growth was -35%. The average annual Inventory growth rates for Dignitana AB have been -2% over the past three years , 3% over the past five years , and 11% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett